Sarcopenia in patients undergoing maintenance hemodialysis: incidence rate, risk factors and its effect on survival risk

References

• Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in older people. Age Ageing. 2010;39:412–423.
   PubMed Web of Science ®Google Scholar
• Domanski M, Ciechanowski K. Sarcopenia: A major challenge in elderly patients with end-stage renal disease. J Aging Res. 2012; 2012:754739.
   PubMedGoogle Scholar
• Greco A, Paroni G, Seripa D, Addante F, Dagostino MP, Aucella F. Frailty, disability and physical exercise in the aging process and in chronic kidney disease. Kidney Blood Pressure Res. 2014;39:164–168.
   PubMed Web of Science ®Google Scholar
• Fahal IH. Uraemic sarcopenia: aetiology and implications. Nephrol Dialysis Transplant. 2014;29:1655–1665.
   PubMed Web of Science ®Google Scholar
• Kim JK, Choi SR, Choi MJ, et al. Prevalence of and factors associated with sarcopenia in elderly patients with end-stage renal disease. Clin Nutr. 2014;33:64–68.
   PubMed Web of Science ®Google Scholar
• Lamarca F, Carrero JJ, Rodrigues JC, Bigogno FG, Fetter RL, Avesani CM. Prevalence of sarcopenia in elderly maintenance hemodialysis patients: The impact of different diagnostic criteria. J Nutr Health Aging. 2014;18:710–717.
   PubMed Web of Science ®Google Scholar
• Tepel M, Echelmeyer M, Orie NN, Zidek W. Increased intracellular reactive oxygen species in patients with end-stage renal failure: Effect of hemodialysis. Kidney Int. 2000;58:867–872.
   PubMed Web of Science ®Google Scholar
• Kalantar-Zadeh K, Kleiner M, Dunne E, Lee GH, Luft FC. A modified quantitative subjective global assessment of nutrition for dialysis patients. Nephrol Dialysis Transplant. 1999;14:1732–1738.
   PubMed Web of Science ®Google Scholar
• Morley JE. Sarcopenia: diagnosis and treatment. J Nutr Health Aging. 2008;12:452–456.
   PubMed Web of Science ®Google Scholar
• Gilson H, Schakman O, Kalista S, Lause P, Tsuchida K, Thissen JP. Follistatin induces muscle hypertrophy through satellite cell proliferation and inhibition of both myostatin and activin. Am J Physiol Endocrinol Metabol. 2009;297:E157–E164.
   PubMed Web of Science ®Google Scholar
• Zhang L, Wang XH, Wang H, Du J, Mitch WE. Satellite cell dysfunction and impaired IGF-1 signaling cause CKD-induced muscle atrophy. J Am Soc Nephrol. 2010;21:419–427.
   PubMed Web of Science ®Google Scholar
• Sayer AA, Syddall H, Martin H, Patel H, Baylis D, Cooper C. The developmental origins of sarcopenia. J Nutr Health Aging. 2008;12:427–432.
   PubMed Web of Science ®Google Scholar
• de Brito-Ashurst I, Varagunam M, Raftery MJ, Yaqoob MM. Bicarbonate supplementation slows progression of CKD and improves nutritional status. J Am Soc Nephrol. 2009;20:2075–2084.
   PubMed Web of Science ®Google Scholar
• den Hoedt CH, Bots ML, Grooteman MP, et al. Clinical predictors of decline in nutritional parameters over time in ESRD. Clin J Am Soc Nephrol. 2014;9:318–325.
   PubMed Web of Science ®Google Scholar
• Siew ED, Pupim LB, Majchrzak KM, Shintani A, Flakoll PJ, Ikizler TA. Insulin resistance is associated with skeletal muscle protein breakdown in non-diabetic chronic hemodialysis patients. Kidney Int. 2007;71:146–152.
   PubMed Web of Science ®Google Scholar
• Fouque D, Pelletier S, Mafra D, Chauveau P. Nutrition and chronic kidney disease. Kidney Int. 2011;80:348–357.
   PubMed Web of Science ®Google Scholar
• von Haehling S, Anker SD. Prevalence, incidence and clinical impact of cachexia: facts and numbers-update 2014. J Cachexia Sarcopenia Muscle. 2014;5:261–263.
   PubMed Web of Science ®Google Scholar
• Fiedler R, Jehle PM, Osten B, Dorligschaw O, Girndt M. Clinical nutrition scores are superior for the prognosis of hemodialysis patients compared to lab markers and bioelectrical impedance. Nephrol Dialysis Transplant. 2009;24:3812–3817.
   PubMed Web of Science ®Google Scholar
• Espahbodi F, Khoddad T, Esmaeili L. Evaluation of malnutrition and its association with biochemical parameters in patients with end stage renal disease undergoing hemodialysis using subjective global assessment. Nephro-Urol Monthly. 2014;6:e16385.
   PubMedGoogle Scholar
• Rambod M, Kovesdy CP, Bross R, Kopple JD, Kalantar-Zadeh K. Association of serum prealbumin and its changes over time with clinical outcomes and survival in patients receiving hemodialysis. Am J Clin Nutr. 2008;88:1485–1494.
   PubMed Web of Science ®Google Scholar
• Chrysostomou S, Stathakis C, Petrikkos G, Daikos G, Gompou A, Perrea D. Assessment of prealbumin in hemodialysis and renal-transplant patients. J Renal Nutr. 2010;20:44–51.
   PubMed Web of Science ®Google Scholar
• Kyle UG, Genton L, Karsegard L, Slosman DO, Pichard C. Single prediction equation for bioelectrical impedance analysis in adults aged 20–94 years. Nutrition. 2001;17:248–253.
   PubMed Web of Science ®Google Scholar
• Oliveira CM, Kubrusly M, Mota RS, Silva CA, Choukroun G, Oliveira VN. The phase angle and mass body cell as markers of nutritional status in hemodialysis patients. J Renal Nutr. 2010;20:314–320.
   PubMed Web of Science ®Google Scholar
• Panzetta G, Tessitore N, Faccini G, Maschio G. The protein catabolic rate as a measure of protein intake in dialysis patients: usefulness and limits. Nephrol Dialysis Transplant. 1990;5(Suppl):125–127.
   Web of Science ®Google Scholar
• Fouque D, Horne R, Cozzolino M, Kalantar-Zadeh K. Balancing nutrition and serum phosphorus in maintenance dialysis. Am J Kidney Dis. 2014;64:143–150.
   PubMed Web of Science ®Google Scholar
• Shinaberger CS, Greenland S, Kopple JD, et al. Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease? Am J Clin Nutr. 2008;88:1511–1518.
   PubMed Web of Science ®Google Scholar
• Kaizu Y, Ohkawa S, Odamaki M, et al. Association between inflammatory mediators and muscle mass in long-term hemodialysis patients. Am J Kidney Dis. 2003;42:295–302.
   PubMed Web of Science ®Google Scholar